Stem and progenitor cells in skeletal muscle development, maintenance, and therapy

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 867-877

  Péault, Bruno ^a,b   Rudnicki, Michael ^c   Torrente, Yvan ^d   Cossu, Giulio ^e   Tremblay, Jacques P ^f   Partridge, Terry ^g   Gussoni, Emanuela ^h   Kunkel, Louis M ^h,i   Huard, Johnny ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF MILAN   (Italy)

^e Stem Cell Research Institute   (Italy)

^f UNIVERSITÉ LAVAL   (Canada)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CADHERIN; CARDIOTOXIN; CD133 ANTIGEN; CYCLOPHOSPHAMIDE; DYSTROPHIN; LENTIVIRUS VECTOR; MATRIX METALLOPROTEINASE; MYOGENIC FACTOR 5; NERVE CELL ADHESION MOLECULE; PARVOVIRUS VECTOR; SHORT HAIRPIN RNA; TACROLIMUS; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TREOSULFAN; VASCULAR CELL ADHESION MOLECULE 1;

ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD VESSEL WALL; CANCER RISK; CELL ACTIVATION; CELL BASED GENE THERAPY; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO CELL; ENDOTHELIUM CELL; GENETIC CODE; GRAFT REJECTION; HUMAN; MULTIPOTENT STEM CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NEPHROTOXICITY; NONHUMAN; NONVIRAL GENE THERAPY; PATIENT SAFETY; PERICYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEPARATION TECHNIQUE; SIDE EFFECT; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; SKIN CELL; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

EID: 34247236574     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.sj.6300145     Document Type: Review

References (145)

1. Mauro, A (1961). Satellite cell of skeletal muscle fibers. J Biophys Biochem 9: 493-495.
2. Sherwood, RI, Christensen, JL, Conboy, IM, Conboy, MJ, Rando, TA, Weissman, IL et al. (2004). Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119: 543-554.
3. Collins, CA, Olsen, I, Zammit, PS, Heslop, L, Petrie, A, Partridge, TA et al. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301.
4. Zammit, PS, Partridge, TA and Yablonka-Reuveni, Z (2006). The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 54: 1177-1191.
5. Beresford, JN, Bennett, JH, Devlin, C, Leboy, PS and Owen, ME (1992). Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102: 341-351.
6. Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
7. Prockop, DJ (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
8. Toma, C, Pittenger, MF, Cahill, KS, Byrne, BJ and Kessler, PD (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
9. Krause, DS, Theise, ND, Collector, MI, Henegariu, O, Hwang, S, Gardner, R et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 1105: 369-377.
10. Mezey, E, Chandross, KJ, Harta, G, Maki, RA and McKercher, SR (2000). Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779-1782.
11. Petersen, BE, Bowen, WC, Patrene, KD, Mars, WM, Sullivan, AK, Murase, N et al. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-1170.
12. Theise, ND, Badve, S, Saxena, R, Henegariu, O, Sell, S, Crawford, JM et al. (2000). Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31: 235-240.
13. Jiang, Y, Vaessen, B, Lenvik, T, Blackstad, M, Reyes, M and Verfaillie, CM (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30: 896-904.
14. Mitchell, KE, Weiss, ML, Mitchell, BM, Martin, P, Davis, D, Morales, L et al. (2003). Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21: 50-60.
15. Wang, HS, Hung, SC, Peng, ST, Huang, CC, Wei, HM, Guo, YJ et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
16. Seaberg, RM, Smukler, SR, Kieffer, TJ, Enikolopov, G, Asghar, Z, Wheeler, MB et al. (2004). Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 22: 1115-1124.
17. Toma, JG, Akhavan, M, Fernandes, KJ, Barnabe-Heider, F, Sadikot, A, Kaplan, DR et al. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778-784.
18. Shih, DT, Lee, DC, Chen, SC, Tsai, RY, Huang, CT, Tsai, CC et al. (2005). Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23: 1012-1020.
19. Zuk, PA, Zhu, M, Mizuno, H, Huang, J, Futrell, JW, Katz, AJ et al. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies, Tissue Eng 7: 211-228.
20. Bischoff, R. (1994). The satellite cell and muscle regeneration. In: Engel, AG and Franszini-Armstrong, C (eds). Myogenesis. McGraw-Hill: New York. pp. 97-118.
21. Charge, SB and Rudnicki, MA (2004). Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238.
22. Hughes, SM and Blau, HM (1990). Migration of myoblasts across basal lamina during skeletal muscle development. Nature 345: 350-353.
23. Yokota, T, Lu, QL, Morgan, JE, Davies, KE, Fisher, R, Takeda, S et al. (2006). Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 119: 2679-2687.
24. Seale, P, Sabourin, LA, Girgis-Gabardo, A, Mansouri, A, Gruss, P and Rudnicki, MA (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786.
25. Irintchev, A, Zeschnigk, M, Starzinski-Pawitz, A and Wernig, A (1994). Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev Dyn 199: 326-337.
26. Cornelison, DD and Wold, BJ (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191: 270-283.
27. Beauchamp, JR, Heslop, L, Yu, DS, Tajbakhsh, S, Kelly, RG, Wernig, A et al. (2000). Expression of CD34 and myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151: 1221-1234.
28. Oustanina, S, Hause, G and Braun, T (2004). Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 23: 3430-3439.
29. Relaix, F, Montarras, D, Zaffran, S, Gayraud-Morel, B; Rocancourt, D, Tajbakhsh, S et al. (2006). Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 172: 91-102.
30. Rosen, GD, Sanes, JR, Lachance, R, Cunningham, JM, Roman, J and Dean, DC (1992). Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69: 1107-1119.
31. Garry, DJ, Yang, Q, Bassel-Duby, R and Williams, RS (1997). Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev Biol 188: 280-294.
32. Comelison, DD, Filla, MS, Stanley, HM, Rapraeger, AC and Olwin, BB (2001). Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 239: 79-94.
33. Seale, P, Ishibashi, J, Holterman, C and Rudnicki, MA (2004). Muscle satellite cell-specific genes identified by genetic profiling of MyoD-deficient myogenic cell. Dev Biol 275: 287-300.
34. Jankowski, RJ, Deasy, BM and Huard, J (2002). Muscle-derived stem cells. Gene Ther 9: 642-647.
35. Thornell, LE, Lindstrom, M, Renault V, Mouly, V and Butler-Browne, GS (2003). Satellite cells and training in the elderly. Scand J Med Sci Sports 13: 48-55.
36. Armand, O, Boutineau, AM, Mauger, A, Pautou, MP and Kieny, M (1983). Origin of satellite cells in avian skeletal muscles. Arch Anat Microsc Morphol Exp 72: 163-181.
37. Kassar-Duchossoy, L, Giacone, E, Gayraud-Morel, B, Jory, A, Gomes, D and Tajbakhsh, S (2005). Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev 19: 1426-1431.
38. Relaix, F, Rocancourt, D, Mansouri, A and Buckingham, M (2005). A Pax3/ Pax7-dependent population of skeletal muscle progenitor cells. Nature 435: 948-953.
39. De Angelis, L, Berghella, L, Coletta, M, Lattanzi, L, Zanchi, M, Cusella-De Angelis, MG et al. (1999). Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147: 869-878.
40. Asakura, A, Seale, P, Girgis-Gabardo, A and Rudnicki, MA (2002). Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159: 123-134.
41. LaBarge, MA and Blau, HM (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111: 589-601.
42. + adult stem cells during muscle regeneration. Cell 113: 841-852.
43. Conboy, IM and Rando, TA (2002). The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 3: 397-409.
44. Zammit, PS, Golding, JP, Nagata, Y, Hudon, V, Partridge, TA and Beauchamp, JR (2004). Muscle satellite cells adopt divergent fates: A mechanism for self-renewal? J Cell Biol 166: 347-357.
45. Mansouri, A, Goudreau, G and Gruss, P (1999). Pax genes and their role in organogenesis. Cancer Res 59: 1707s-1709s; discussion 1709s-1710s.
46. Goulding, MD, Chalepakis, G, Deutsch, U, Ersellus, JR and Gruss, P (1991). Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 10: 1135-1147.
47. Jostes, B, Walther, C and Gruss, P (1990). The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech Dev 33: 27-37.
48. Maroto, M, Reshef, R, Munsterberg, AE, Koester, S, Goulding, M and Lassar AB (1997). Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89: 139-148.
49. Tajbakhsh, S, Rocancourt, D, Cossu, G and Buckingham, M (1997). Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89: 127-138.
50. Schafer, BW, Czemy, T, Bernasconi, M, Genini, M and Busslinger, M (1994). Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucleic Acids Res 22: 4574-4582.
51. Bennicelli, JL, Advani, S, Schafer, BW and Barr, FG (1999). PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Oncogene 18: 4348-4356.
52. Conway, SJ, Henderson, DJ and Copp, AJ (1997). Pax3 is required for cardiac neural crest migration in the mouse: Evidence from the splotch (Sp2H) mutant. Development 124: 505-514.
53. Tremblay, P, Dietrich, S, Mericskay M, Schubert, FR, Li, Z and Paulin, D (1998). A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev Biol 203: 49-61.
54. -/- mutant mice. Development 122: 831-838.
55. + stem cells from injured muscle. PLoS Biol 2: E130.
56. Daston, G, Lamar, E, Olivier, M and Goulding, M (1996). Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122: 1017-1027.
57. Epstein, JA, Lam, P, Jepeal, L, Maas, RL and Shapiro, DN (1995). Pax3 inhibits myogenic differentiation of cultured myoblast cells. J Biol Chem 270: 11719-11722.
58. Williams, BA and Ordahl, CP (1994). Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. Development 120: 785-796.
59. Borycki, AG and Emerson, CP (1997). Muscle determination: Another key player in myogenesis? Curr Biol 7: R620-R623.
60. Khan, J, Bittner, ML, Saal, LH, Teichmann, U, Azorsa, DO, Gooden, GC et al. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96: 13264-13269.
61. Kuang, S, Charge, SB, Seale, P, Huh, M and Rudnicki, MA (2006). Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 172: 103-113.
62. McKinnell, IW, Parise, G and Rudnicki, MA (2005). Muscle stem cells and regenerative myogenesis. Curr Top Dev Biol 71: 113-130.
63. Partridge, TA, Morgan, JE, Coulton, GR, Hoffman, EP and Kunkel, LM (1989). Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 337: 176-179.
64. Huard, J, Bouchard, JP, Roy, R, Labrecque, C, Dansereau, G, Lemieux, B et al. (1991). Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy, Clin Sci (Lond) 81: 287-288.
65. Huard, J, Bouchard, JP, Roy, R, Malouin, F, Dansereau, G, Labrecque, C et al. (1992). Human myoblast transplantation: Preliminary results of 4 cases. Muscle Nerve 15: 550-560.
66. Tremblay, JP, Bouchard, JP, Malouin, F, Theau, D, Cottrell, F, Collin, H et al. (1993). Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul Disord 3: 583-592.
67. Tremblay, JP, Malouin, F, Roy, P, Huard, J, Bouchard, JP, Satoh, A et al. (1993). Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2: 99-112.
68. Karpati, G, Ajdukovic, D, Arnold, D, Gledhill, RB, Guttmann, R, Holland, P et al. (1993). Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 34: 8-17.
69. Gussoni, E, Pavlath, GK, Lanctot, AM, Sharma, KR, Miller, RG, Steinman, L et al. (1992). Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356: 435-438.
70. Miller, RG, Sharma, KR, Pavlath, GK, Gussoni, E, Mynhier, M, Lanctot, AM et al. (1997). Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle Nerve 20: 469-478.
71. Mendell, JR, Kissel, JT, Amato, AA, King, W, Signore, L, Prior, TW et al. (1995). Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 333: 832-838.
72. Vilquin, JT, Kinoshita, I, Roy, R and Tremblay, JP (1995). Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse. Neuromuscul Disord 5: 511-517.
73. Guerette, B, Asselin, I, Skuk, D, Entman, M and Tremblay, JP (1997). Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant 6: 101-107.
74. Huard, J, Acsadi, G, Jani, A, Massie, B and Karpati, G (1994). Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 5: 949-958.
75. Fan, Y, Maley, M, Beilharz, M and Grounds, M (1996). Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19: 853-860.
76. Skuk, D, Roy, B, Goulet, M and Tremblay, JP (1999). Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 155 22-30.
77. Guerette, B, Asselin, I, Vilquin, JT, Roy, R and Tremblay, JP (1994). Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice. Transplant Proc 26: 3461-3462.
78. Hardiman, O, Sklar, RM and Brown, RH Jr. (1993). Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture. Neurology 43: 1432-1434.
79. Hong, F, Lee, J, Song, JW, Lee, SJ, Ahn, H, Cho, JJ et al. (2002). Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: Cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 16: 1633-1635.
80. Kinoshita, I, Roy, R, Dugre, FJ, Gravel, C, Roy, B, Goulet, M et al. (1996). Myoblast transplantation in monkeys: Control of immune response by FK506. J Neuropathol Exp Neurol 55: 687-697.
81. Kinoshita, I, Vilquin, JT, Guerette, B, Asselin, I, Roy, R and Tremblay, JP (1994). Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 17: 1407-1415.
82. Smythe, GM and Grounds, MD (2001). Absence of MyoD increases donor myoblast migration into host muscle. Exp Cell Res 267: 267-274.
83. El Fahime, E, Torrente, Y, Caron, NJ, Bresolin, MD and Tremblay, JP (2000). In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 258: 279-287.
84. Cousins, JC, Woodward, KJ, Gross, JG, Partridge, TA and Morgan, JE (2004). Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J Cell Sci 117: 3259-3269.
85. Skuk, D, Roy, B, Goulet, M, Chapdelaine, P, Bouchard, JP, Roy, R et al. (2004). Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 9: 475-482.
86. Skuk, D, Goulet, M, Roy, B, Chapdelaine, P, Bouchard, IP, Roy, R et al. (2006). Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 65: 371-386.
87. Skuk, D, Goulet, M, Roy, B, Piette, V, Cote, CH, Chapdelaine, P et al. (2007). First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 17: 38-46.
88. Camirand, G, Rousseau, J, Ducharme, ME, Rothstein, DM and Tremblay, JP (2004). Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am J Transplant 4: 1255-1265.
89. Stephan, L, Pichavant, C, Bouchentouf, M, Mills, P, Camirand, G, Tagmouti, S et al. Induction of tolerance across fully mismatched barriers by a non-myeloablative treatment excluding antibodies and irradiation. Cell Transplant 15: 835-846.
90. Quenneville, SP, Chapdelaine, P, Skuk, D, Paradis, M, Goulet, M, Rousseau, J et al. Autologous transplantation of muscle precursor cells genetically modified with a lentivirus for muscular dystrophy: human cells and primates models. Mol Ther 15: 431-438.
91. Goncalves, MA, Holkers, M, Cudre-Mauroux, C, van Nierop, GP, Knaan-Shanzer, S, van der Velde, I et al. (2006). Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells. Mol Ther 13: 976-986.
92. Floyd, SS Jr., Clemens, PR, Ontell, MR, Kochanek, S, Day, CS, Yang, J et al. (1998). Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene ther 5: 19-30.
93. Di Rocco, G, Iachininoto, MG, Tritarelli, A, Straino, S, Zacheo, A, Germani, A et al. (2006). Myogenic potential of adipose-tissue-derived cells. J Cell Sci 119: 2945-2952.
94. El Fahime, E, Mills, P, Lafreniere, JF, Torrente, Y and Tremblay, JP (2002). The urokinase plasminogen activator: An interesting way to improve myoblast migration following their transplantation. Exp Cell Res 280: 169-178.
95. Lafreniere, JF, Mills, P, Tremblay, JP and Fahime, EE (2004). Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 77: 1741-1747.
96. Gussoni, E, Soneoka, Y, Strickland, CD, Buzney, EA, Khan, MK, Flint, AF et al. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-394.
97. Jackson, KA, Mi, T and Goodell, MA (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 96: 14482-14486.
98. Goodell, MA, Brose, K, Paradis, G, Conner, AS and Mulligan, RC (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
99. Montanaro, F, Liadaki, K, Volinski, J, Flint, A and Kunkel, LM (2003). Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc Natl Acad Sci USA 100: 9336-9341.
100. Montanaro, F, Liadaki, K, Schienda, J, Flint, A, Gussoni, E and Kunkel, LM (2004). Demystifying SP cell purification: Viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res 298 144-154.
101. Liadaki, K, Kho, AT, Sanoudou, D, Schienda, J, Flint, A, Beggs, AH et al. (2005). Side population cells isolated from different tissues share transcriptome signatures and express tissue-specific markers. Exp Cell Res 303: 360-374.
102. Bachrach, E, Li, S, Perez, AL, Schienda, J, Liadaki, K, Volinski, J, Flint, A et al. (2004). Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci USA 101: 3581-3586.
103. McKinney-Freeman, SL, Jackson, KA, Camargo, FD, Ferrari, G, Mavilio, F and Goodell, MA (2002). Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 99: 1341-1346.
104. McKinney-Freeman, SL, Maika, SM, Jackson, KA, Norwood, K, Hirschi, KK and Goodell, MA (2003). Altered phenotype and reduced function of muscle-derived hematopoietic stem cells. Exp Hematol 31: 806-814.
105. Asakura, A and Rudnicki, MA (2002). Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 30: 1339-1345.
106. Schienda, J, Engleka, KA, Jun, S, Hansen, MS, Epstein, JA, Tabin, CJ et al. (2006). Somitic origin of limb muscle satellite and side population cells. Proc Natl Acad Sci USA 103: 945-950.
107. Rivier, F, Alkan, O, Flint AF, Muskiewicz, K, Allen, PD, Leboulch, P et al. (2004). Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. J Cell Sci 117: 1979-1988.
108. Bachrach, E, Perez, AL, Choi, YH, Illigens, BM, Jun, SJ, del Nido, P et al. (2006). Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve 34: 44-52.
109. Pavlath, GK and Gussoni, E (2005). Human myoblasts and muscle-derived SP cells. Methods Mol Med 107: 97-110.
110. Frank, NY, Kho, AT, Schatton, T, Murphy, GF, Molloy, MJ, Zhan, Q et al. (2006). Regulation of myogenic progenitor proliferation in human skeletal muscle by BMP 4 and its antagonist gremlin. J Cell Biol 175: 99-110.
111. Cossu, G and Biressi, S (2005). Satellite cells, myoblasts and other occasional myogenic progenitors: Possible origin, phenotypic features and role in muscle regeneration. Semin Cell Dev Biol 16: 623-631.
112. Cao, B and Huard, J (2004). Muscle-derived stem cells. Cell Cyde 3: 104-107.
113. Minasi, MG, Riminucci, M, De Angelis, L, Borello, U, Berarducci, B, Innocenzi, A et al. (2002). The meso-angioblast: A multipotent, setf-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129 2773-2783.
114. Sampaolesi, M, Torrente, Y, Innocenzi, A, Tonlorenzi, R, D'Antona, G, Pellegrino, MA et al. (2003). Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangloblasts. Science 301: 487-492.
115. Galvez, BG, Sampaolesi, M, Brunelli, S, Covarello, D, Gavina, M, Rossi, B et al. (2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 174: 231-243.
116. Dellavalle, A, Sampaolesi, M, Tonlorenzi, R, Tagliafico, E, Sacchetti, B, Perani, L, et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat cell Biol 9: 255-267.
117. Sampaolesi, M, Blot S, D'Antona, G, Granger, N, Tonlorenzi, R, Innocenzi, A et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
118. + stem cells after intra-arterial transplantation. Blood 108: 2857-2866.
119. + stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114: 182-195.
120. Allen, DL, Teitelbaum, DH and Kurachi, K (2003). Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 284 C805-C815.
121. Corti, S, Salani, S, Del Bo, R, Sironi, M, Strazzer, S, D'Angelo, MG et al. (2001). Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res 268: 36-44.
122. Lafreniere, JF, Mills, P, Bouchentouf, M and Tremblay, JP (2006). Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 312: 1127-1141.
123. Torrente, Y, El Fahime, E, Caron, NJ, Del Bo, R, Belicchi, M, Pisati, F et al. (2003). Tumor necrosis factor-α (TNF-α) stimulates chemotactic response in mouse myogenic cells. Cell Transplant 12: 91-100.
124. Ferrari, G, Cusella-De Angelis, G, Coletta, M, Paolucci, E, Stomaiuolo, A, Cossu, G et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-1530.
125. + marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951-955.
126. Torrente, Y, Camirand, G, Pisati, F, Belicchi, M, Rossi, B, Colombo, F et al. (2003). Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 162: 511-520.
127. Qu-Petersen, Z, Deasy, B, Jankowski, R, Ikezawa, M, Cummins, J, Pruchnic, R et al. (2002). Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 157: 851-864.
128. Nomura, T, Ashihara, E, Tateishi, K, Asada, S, Ueyama, T, Takahashi, T et al. (2007). Skeletal myosphere-derived progenitor cell transplantation promotes neovascularization in delta-sarcoglycan knockdown cardiomyopathy. Biochem Biophys Res Common 352: 668-674.
129. Sarig, R, Baruchi, Z, Fuchs, O, Nudel, U and Yaffe, D (2006). Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem cells 24: 1769-1778.
130. Winitsky, SO, Gopal, TV, Hassanzadehl, S, Takahashi, H, Gryder, D, Rogawski, MA et al. (2005). Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 3: E87.
131. Lee-Pullen, TF, Bennett AL, Beilharz, MW, Grounds, MD and Sammels, LM (2004). Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice. Transplantation 78:1172-1176.
132. Deasy, B, Lu, A, Tebbets, JC, Feduska, JM, Schugar, RC, Pollett, JB et al. A role for cell sex in stem cell mediated skeletal muscle regeneration: Female cells have higher muscle regeneration efficiency J Cell Biol (in press).
133. Mueller, GM, O'Day, T, Watchko, JF and Ontell, M (2002). Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Hum Gene Ther 13: 1081-1090.
134. Jankowski, RJ, Deasy, BM, Cao, B, Gates, C and Huard, J (2002). The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 115: 4361-4374.
135. Jankowski, RJ and Huard, J (2004). Myogenic cellular transplantation and regeneration: Sorting through progenitor heterogeneity. Panminerva Med 46: 81-91.
136. Oshima, H, Payne, TR, Urish, KL, Sakai, T, Ling, Y, Gharaibeh, B et al. (2005). Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12: 1130-1141.
137. Payne, TR, Oshima, H, Sakai, T, Ling, Y, Gharaibeh, B, Cummins, J et al. (2005). Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 12: 1264-1274.
138. Oberlin, E, Tavian, M, Blazsek, I and Peault, B (2002). Blood-forming potential of vascular endothelium in the human embryo. Development 129: 4147-4157.
139. Zambidis, ET, Oberlin, E, Tavian, M and Peault, B (2006). Blood-forming endothelium in human ontogeny: Lessons from in utero development and embryonic stem cell culture. Trends Cardiovasc Med 16: 95-101.
140. Andreeva, ER, Pugach, IM, Gordon, D and Orekhov, AN (1998). Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 30: 127-135.
141. Betsholtz, C, Lindblom, P and Gerhardt, H (2005). Role of pericytes in vascular morphogenesis. Exs 115-125.
142. Alliot-Licht, B, Bluteau, G, Magne, D, Lopez-Cazaux, S, Lieubeau, B, Daculsi, G et al. (2005). Dexamethasone stimulates differentiation of odontoblast-like cells in human dental pulp cultures. Cell Tissue Res 321: 391-400.
143. Collett, GD and Canfield, AE (2005). Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 96: 930-938.
144. Farrington-Rock, C, Crofts, NJ, Doherty, MJ, Ashton, BA, Griffin-Jones, C and Canfield, AE (2004). Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110: 2226-2232.
145. Kamochi, H, Kurokawa, MS, Yoshikawa, H, Ueda, Y, Masuda, C, Takada, E et al. (2006). Transplantation of myocyte precursors derived from embryonic stem cells transfected with IGFII gene in a mouse model of muscle injury. Transplantation. 82: 516-526.